JP2011513393A - 眼用組成物 - Google Patents

眼用組成物 Download PDF

Info

Publication number
JP2011513393A
JP2011513393A JP2010549260A JP2010549260A JP2011513393A JP 2011513393 A JP2011513393 A JP 2011513393A JP 2010549260 A JP2010549260 A JP 2010549260A JP 2010549260 A JP2010549260 A JP 2010549260A JP 2011513393 A JP2011513393 A JP 2011513393A
Authority
JP
Japan
Prior art keywords
composition
cps
viscosity
weight
ophthalmic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010549260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513393A5 (enExample
Inventor
アリンダム、ハルダー
アジャイ、ジャイシン、コペイド
スブハス、バララム、ボウミック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharma Advanced Research Co Ltd
Original Assignee
Sun Pharma Advanced Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Research Co Ltd filed Critical Sun Pharma Advanced Research Co Ltd
Publication of JP2011513393A publication Critical patent/JP2011513393A/ja
Publication of JP2011513393A5 publication Critical patent/JP2011513393A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2010549260A 2008-03-07 2009-03-09 眼用組成物 Pending JP2011513393A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN477MU2008 2008-03-07
PCT/IN2009/000162 WO2009110009A2 (en) 2008-03-07 2009-03-09 Opthalmic composition

Publications (2)

Publication Number Publication Date
JP2011513393A true JP2011513393A (ja) 2011-04-28
JP2011513393A5 JP2011513393A5 (enExample) 2012-03-08

Family

ID=41056432

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549260A Pending JP2011513393A (ja) 2008-03-07 2009-03-09 眼用組成物

Country Status (9)

Country Link
US (1) US20110003816A1 (enExample)
EP (1) EP2249871A4 (enExample)
JP (1) JP2011513393A (enExample)
KR (1) KR20100133980A (enExample)
CN (1) CN101977630B (enExample)
BR (1) BRPI0909797A2 (enExample)
CA (1) CA2717825A1 (enExample)
MX (1) MX2010009857A (enExample)
WO (1) WO2009110009A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014515383A (ja) * 2011-05-27 2014-06-30 レイショファーム ゲゼルシャフト ミット ベシュレンクテル ハフツング ＰＧＦ２α類似体を含む眼科用製剤
JP2015101582A (ja) * 2013-11-28 2015-06-04 ライオン株式会社 眼科用組成物
WO2023054669A1 (ja) * 2021-09-30 2023-04-06 ロート製薬株式会社 眼科組成物
US12296014B2 (en) 2018-09-07 2025-05-13 Farnex Incorporated External preparation comprising non-lamellar liquid crystal-forming lipid

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2979689A1 (en) * 2014-07-29 2016-02-03 Sygene Technologies Composition for an eye drop and delivery system therefor
CN106619573B (zh) * 2016-12-27 2019-09-20 广州中大南沙科技创新产业园有限公司 马来酸噻吗洛尔立方液晶纳米粒滴眼液及其制备方法
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
US20210000844A1 (en) * 2018-02-28 2021-01-07 Santen Pharmaceutical Co., Ltd. Ophthalmic composition comprising diquafosol and cationic polymer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5998016A (ja) * 1982-10-27 1984-06-06 ユ−エスヴイ−・フア−マシユ−テイカル・コ−ポレ−シヨン 緑内障治療用セリプロロ−ル
JPH08500354A (ja) * 1992-08-20 1996-01-16 レイラス オイ 眼科治療用製剤
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US20040247679A1 (en) * 2003-06-03 2004-12-09 Biokey, Inc. Pharmaceutical composition and method for treating

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE69212850T2 (de) * 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
JP2719049B2 (ja) * 1991-01-28 1998-02-25 日本碍子株式会社 ランタンクロマイト膜の製造方法及び固体電解質型燃料電池用インターコネクターの製造方法
US6645963B2 (en) * 1997-11-05 2003-11-11 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
PT1244438E (pt) * 1999-11-30 2004-02-27 Alcon Inc Utilizacao de antagonistas dos receptores beta-adrenergicos para o fabrico de um medicamento destinado ao tratamento de perturbacoes da retina externa
CN1413114A (zh) * 1999-12-27 2003-04-23 参天制药株式会社 用于稳定泪液层的体系
WO2004103373A1 (ja) * 2003-05-23 2004-12-02 Santen Pharmaceutical Co.,Ltd. キノロン系抗菌化合物を含有する点眼液
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839898C (en) * 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
US20060292101A1 (en) * 2005-06-28 2006-12-28 Roya Borazjani In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5998016A (ja) * 1982-10-27 1984-06-06 ユ−エスヴイ−・フア−マシユ−テイカル・コ−ポレ−シヨン 緑内障治療用セリプロロ−ル
JPH08500354A (ja) * 1992-08-20 1996-01-16 レイラス オイ 眼科治療用製剤
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US20040247679A1 (en) * 2003-06-03 2004-12-09 Biokey, Inc. Pharmaceutical composition and method for treating

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXPERIMENTAL EYE RESEARCH, vol. 54, no. 5, JPN6013038958, 1992, pages 747 - 757, ISSN: 0002601917 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014515383A (ja) * 2011-05-27 2014-06-30 レイショファーム ゲゼルシャフト ミット ベシュレンクテル ハフツング ＰＧＦ２α類似体を含む眼科用製剤
JP2015101582A (ja) * 2013-11-28 2015-06-04 ライオン株式会社 眼科用組成物
KR101858590B1 (ko) 2013-11-28 2018-05-16 라이온 가부시키가이샤 안과용 조성물
US12296014B2 (en) 2018-09-07 2025-05-13 Farnex Incorporated External preparation comprising non-lamellar liquid crystal-forming lipid
WO2023054669A1 (ja) * 2021-09-30 2023-04-06 ロート製薬株式会社 眼科組成物

Also Published As

Publication number Publication date
WO2009110009A3 (en) 2009-12-23
CN101977630B (zh) 2012-11-21
CN101977630A (zh) 2011-02-16
US20110003816A1 (en) 2011-01-06
WO2009110009A2 (en) 2009-09-11
EP2249871A2 (en) 2010-11-17
CA2717825A1 (en) 2009-09-11
MX2010009857A (es) 2010-12-07
EP2249871A4 (en) 2011-03-16
BRPI0909797A2 (pt) 2017-08-22
KR20100133980A (ko) 2010-12-22

Similar Documents

Publication Publication Date Title
US12409175B2 (en) Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
TWI361701B (en) Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye
JP5877885B2 (ja) 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム
CA2987787C (en) Compositions for the improvement of distance vision and the treatment of refractive errors of the eye
CN101977630B (zh) 眼药组合物
US20140228364A1 (en) Ophthalmic Compositions Comprising Prostaglandin F2 Alpha Derivatives and Hyaluronic Acid
SA521430043B1 (ar) صياغات من المركب 4-(7- هيدروكسي-2- أيزوبروبيل-4- أوكسو-4h- كوينازولين-3- يل) - بنزونيتريل
WO2017066052A1 (en) Formulations and methods for treating high intraocular pressure
JP2022511335A (ja) 人工涙液組成物、コンタクトレンズ組成物及び薬剤ビヒクル組成物、並びにこれらの使用の方法
TW202333700A (zh) 用於治療眼病之組成物及方法
JP2023530188A (ja) 高分子量ヒアルロン酸の眼科用薬物輸送ビヒクルとしての使用
KR102268002B1 (ko) 효과 지속성 점안제 조성물
TW202333662A (zh) 增強抗老花眼效果之卡巴可(carbachol)調配物
KR100938233B1 (ko) 프로스타글란딘계 점안용 조성물과 그의 제조 방법
Halder et al. A gel-free reservoir system for once-a-day ophthalmic delivery of Timolol maleate
EP4454639A1 (en) Ophthalmic composition comprising carbomer and taurine
EP1749541B1 (en) Eyedrops
WO2025264886A1 (en) Ophthalmic preparations and methods of use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130806

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140325